NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 45 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $154,000 | – | 25,741 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 5,000 | $3,000 | 0.00% |